Home » Topics » Conferences

Conferences
RSS

Bosentan evaluated in humans for preventing ciclosporin nephrotoxicity

Sep. 29, 1997

New oxazolidinone from P&U described at ICAAC

Sep. 29, 1997

Synaptic focuses on dihydropyrimidinones for BPH

Sep. 29, 1997

Design and synthesis of COX-2 inhibitors related to indomethacin

Sep. 29, 1997

SB-244875: a new bone resorption inhibitor

Sep. 29, 1997

Sumitomo prepares bone-selective bisphosphonate-estrogen conjugates

Sep. 29, 1997

Zeneca describes SAR for new asthma therapy in development

Sep. 29, 1997

Phosphomannose isomerase as target for antifungal drugs

Sep. 29, 1997

Naramig safe and effective for acute treatment of migraine

Sep. 26, 1997

Fluvastatin safely and effectively improves lipid profiles in transplant recipients

Sep. 26, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...